- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 239/52 - Deux atomes d'oxygène
Détention brevets de la classe C07D 239/52
Brevets de cette classe: 248
Historique des publications depuis 10 ans
25
|
15
|
18
|
13
|
19
|
16
|
6
|
7
|
8
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Merck Sharp & Dohme LLC | 3753 |
10 |
Bayer Cropscience AG | 2014 |
6 |
Nutrichem Company Limited | 16 |
6 |
Shangyu Nutrichem Co., Ltd. | 7 |
6 |
UPL Limited | 594 |
6 |
Syngenta Limited | 448 |
5 |
Galderma Research & Development | 398 |
5 |
Ihara Chemical Industry Co., Ltd. | 68 |
5 |
Melior Pharmaceuticals I, Inc. | 25 |
5 |
Arizona Board of Regents on behalf of Arizona State University | 2673 |
4 |
R.J. Reynolds Tobacco Company | 504 |
4 |
F. Hoffmann-La Roche AG | 7948 |
3 |
BASF SE | 21017 |
3 |
The Regents of the University of California | 20108 |
3 |
Merck Sharp & Dohme Corp. | 2190 |
3 |
Boehringer Ingelheim International GmbH | 4640 |
3 |
Syngenta Participations AG | 1833 |
3 |
The Trustees of Columbia University in the City of New York | 3589 |
3 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2188 |
3 |
The Brigham and Women's Hospital, Inc. | 2215 |
3 |
Autres propriétaires | 159 |